148 related articles for article (PubMed ID: 30772682)
1. GMP-compatible manufacturing of three iPS cell lines from human peripheral blood.
Haase A; Glienke W; Engels L; Göhring G; Esser R; Arseniev L; Martin U
Stem Cell Res; 2019 Mar; 35():101394. PubMed ID: 30772682
[TBL] [Abstract][Full Text] [Related]
2. Generation of clinical-grade human induced pluripotent stem cells in Xeno-free conditions.
Wang J; Hao J; Bai D; Gu Q; Han W; Wang L; Tan Y; Li X; Xue K; Han P; Liu Z; Jia Y; Wu J; Liu L; Wang L; Li W; Liu Z; Zhou Q
Stem Cell Res Ther; 2015 Nov; 6():223. PubMed ID: 26564165
[TBL] [Abstract][Full Text] [Related]
3. Generation of human induced pluripotent stem cells using genome integrating or non-integrating methods.
Šimara P; Tesařová L; Padourová S; Koutná I
Folia Biol (Praha); 2014; 60 Suppl 1():85-9. PubMed ID: 25369347
[TBL] [Abstract][Full Text] [Related]
4. Safety of GMP-compliant iPSC lines generated by Sendai virus transduction is dependent upon clone identity and sex of the donor.
Kuczynska Z; Neglur PK; Metin E; Liput M; Zychowicz M; Zayat V; Krześniak NE; Buzanska L; Kot M
Folia Neuropathol; 2024; 62(1):32-46. PubMed ID: 38741435
[TBL] [Abstract][Full Text] [Related]
5. Good Manufacturing Practice-compliant human induced pluripotent stem cells: from bench to putative clinical products.
Novoa JJ; Westra IM; Steeneveld E; Fonseca Neves N; Arendzen CH; Rajaei B; Grundeken E; Yildiz M; van der Valk W; Salvador A; Carlotti F; Dijkers PF; Locher H; van den Berg CW; Raymond KI; Kirkeby A; Mummery CL; Rabelink TJ; Freund C; Meij P; Wieles B
Cytotherapy; 2024 Jun; 26(6):556-566. PubMed ID: 38483359
[TBL] [Abstract][Full Text] [Related]
6. Generation of non-transgenic iPS cells from human cord blood CD34
Haase A; Göhring G; Martin U
Stem Cell Res; 2017 May; 21():71-73. PubMed ID: 28677540
[TBL] [Abstract][Full Text] [Related]
7. Generation of Human Induced Pluripotent Stem Cells Using a Defined, Feeder-Free Reprogramming System.
Park S; Mostoslavsky G
Curr Protoc Stem Cell Biol; 2018 May; 45(1):e48. PubMed ID: 30040234
[TBL] [Abstract][Full Text] [Related]
8. Xeno-Free Reprogramming of Peripheral Blood Mononuclear Erythroblasts on Laminin-521.
Skorik C; Mullin NK; Shi M; Zhang Y; Hunter P; Tang Y; Hilton B; Schlaeger TM
Curr Protoc Stem Cell Biol; 2020 Mar; 52(1):e103. PubMed ID: 31977148
[TBL] [Abstract][Full Text] [Related]
9. Derivation of GMP-compliant integration-free hiPSCs using modified mRNAs.
Durruthy JD; Sebastiano V
Methods Mol Biol; 2015; 1283():31-42. PubMed ID: 25304205
[TBL] [Abstract][Full Text] [Related]
10. cGMP-Manufactured Human Induced Pluripotent Stem Cells Are Available for Pre-clinical and Clinical Applications.
Baghbaderani BA; Tian X; Neo BH; Burkall A; Dimezzo T; Sierra G; Zeng X; Warren K; Kovarcik DP; Fellner T; Rao MS
Stem Cell Reports; 2015 Oct; 5(4):647-59. PubMed ID: 26411904
[TBL] [Abstract][Full Text] [Related]
11. Reprogramming Methods Do Not Affect Gene Expression Profile of Human Induced Pluripotent Stem Cells.
Trevisan M; Desole G; Costanzi G; Lavezzo E; Palù G; Barzon L
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28117672
[TBL] [Abstract][Full Text] [Related]
12. Reprogramming of bone marrow derived mesenchymal stromal cells to human induced pluripotent stem cells from pediatric patients with hematological diseases using a commercial mRNA kit.
Sfougataki I; Grafakos I; Varela I; Mitrakos A; Karagiannidou A; Tzannoudaki M; Poulou M; Mertzanian A; Roubelakis G M; Stefanaki K; Traeger-Synodinos J; Kanavakis E; Kitra V; Tzetis M; Goussetis E
Blood Cells Mol Dis; 2019 May; 76():32-39. PubMed ID: 30709626
[TBL] [Abstract][Full Text] [Related]
13. The Aberrant DNA Methylation Profile of Human Induced Pluripotent Stem Cells Is Connected to the Reprogramming Process and Is Normalized During In Vitro Culture.
Tesarova L; Simara P; Stejskal S; Koutna I
PLoS One; 2016; 11(6):e0157974. PubMed ID: 27336948
[TBL] [Abstract][Full Text] [Related]
14. Robust Differentiation of mRNA-Reprogrammed Human Induced Pluripotent Stem Cells Toward a Retinal Lineage.
Sridhar A; Ohlemacher SK; Langer KB; Meyer JS
Stem Cells Transl Med; 2016 Apr; 5(4):417-26. PubMed ID: 26933039
[TBL] [Abstract][Full Text] [Related]
15. Nonintegrating Human Somatic Cell Reprogramming Methods.
Schlaeger TM
Adv Biochem Eng Biotechnol; 2018; 163():1-21. PubMed ID: 29075799
[TBL] [Abstract][Full Text] [Related]
16. Reprogramming of Human Fibroblasts to Induced Pluripotent Stem Cells with Sleeping Beauty Transposon-Based Stable Gene Delivery.
Sebe A; Ivics Z
Methods Mol Biol; 2016; 1400():419-27. PubMed ID: 26895068
[TBL] [Abstract][Full Text] [Related]
17. Efficient Generation of Non-Integration and Feeder-Free Induced Pluripotent Stem Cells from Human Peripheral Blood Cells by Sendai Virus.
Ye H; Wang Q
Cell Physiol Biochem; 2018; 50(4):1318-1331. PubMed ID: 30355953
[TBL] [Abstract][Full Text] [Related]
18. Virus-free and oncogene-free induced pluripotent stem cell reprogramming in cord blood and peripheral blood in patients with lung disease.
Kamath A; Ternes S; McGowan S; Moy AB
Regen Med; 2018 Dec; 13(8):889-915. PubMed ID: 30488785
[TBL] [Abstract][Full Text] [Related]
19. Development of a protein marker panel for characterization of human induced pluripotent stem cells (hiPSCs) using global quantitative proteome analysis.
Pripuzova NS; Getie-Kebtie M; Grunseich C; Sweeney C; Malech H; Alterman MA
Stem Cell Res; 2015 May; 14(3):323-38. PubMed ID: 25840413
[TBL] [Abstract][Full Text] [Related]
20. Development of genetic quality tests for good manufacturing practice-compliant induced pluripotent stem cells and their derivatives.
Jo HY; Han HW; Jung I; Ju JH; Park SJ; Moon S; Geum D; Kim H; Park HJ; Kim S; Stacey GN; Koo SK; Park MH; Kim JH
Sci Rep; 2020 Mar; 10(1):3939. PubMed ID: 32127560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
